Patients Discontinuing Weight-Loss Jabs Put On Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Fresh analysis reveals that people who discontinue new slimming jabs like Mounjaro or Wegovy may regain lost weight far faster than those who end traditional lifestyle programs.

Research printed in a major health publication shows that while obese people frequently drop a large proportion of their body weight while on the medication, the weight is regained at an estimated rate of 0.8 kg per month after stopping.

"Individuals using such medications need to be cognizant of the danger of rapid weight regain when the medication ends," warns researcher Dr. Susan Jebb.

This pace of recovery means a return to pre-treatment mass within about a year and a half.

Analyzing Treatments

The research, which reviewed dozens of trials involving thousands of patients, contrasted the effects of GLP-1 agonists with conventional dieting.

The team emphasize that individuals who lose weight through lifestyle changes alone usually see a less rapid weight regain—perhaps 100 grams monthly—once they finish.

The Reason for the Fast Rebound

Experts believe the way of the jabs accounts for the accelerated rebound.

The injections copy a body's own chemical called glucagon-like peptide-1, which controls appetite.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.

"Stopping of this hormone supplement leads to hunger is uncontrolled, making excessive eating far more likely."

A Chronic Condition?

Medical guidelines recommend the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.

A number of clinicians say that, due to the likelihood of weight regain, the therapy is often life-long.

This view is echoed by drug manufacturers, who say that the findings "emphasize the persistent character of obesity," similar to managing diseases like hypertension.

Patient Testimonies

Individuals who have discontinued the medication describe a sudden resurgence of appetite.

"It was like a trigger that goes on and you become extremely hungry," described an individual.

The struggle is worsened if users have not adopted permanent dietary or behavioural modifications during treatment.

Significant Use

Recent estimates show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.

• Adoption is higher among females than males.
• The middle-aged age group shows the greatest usage rates.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Ultimately, researchers emphasize that while the jabs are potent agents for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on combined lifestyle support.